日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

Outcome and safety of single-dose docetaxel-augmented targeted radionuclide therapy using [¹⁷⁷Lu]Lu-PSMA-617 radioligand therapy in treatment-refractory mCRPC: preliminary evidence from a pilot experience

使用[¹⁷⁷Lu]Lu-PSMA-617放射性配体进行单剂量多西他赛增强靶向放射性核素治疗治疗难治性转移性去势抵抗性前列腺癌的疗效和安全性：一项试点研究的初步证据

期刊:Ejnmmi Research
影响因子:3
doi:10.1186/s13550-026-01408-w
Ebert, Niklas; Rosar, Florian; Burgard, Caroline; Bartholomä, Mark; Maus, Stephan; Hein, Connor; Blickle, Arne; Ezziddin, Samer; Khreish, Fadi
肿瘤
前列腺癌
肿瘤免疫
发表日期：2026
文献求助 收藏

Auger Emitting [(161)Tb]Tb-PSMA-617 Radioligand Therapy in mCRPC with Peritoneal Carcinomatosis

俄歇发射[(161)Tb]Tb-PSMA-617放射性配体疗法治疗伴有腹膜癌的转移性去势抵抗性前列腺癌

期刊:Nuclear Medicine and Molecular Imaging
影响因子:2.7
doi:10.1007/s13139-025-00973-7
Rosar, Florian; Blickle, Arne; Bastian, Moritz B; Speicher, Tilman; Schaefer-Schuler, Andrea; Burgard, Caroline; Maus, Stephan; Ezziddin, Samer
肿瘤
前列腺癌
肿瘤免疫
发表日期：2026
文献求助 收藏

Pilot experience of [(161)Tb]Tb-PSMA-617 RLT in mCRPC patients after conventional PSMA RLT within a prospective registry

在前瞻性注册研究中，对接受常规PSMA放射性激光治疗的转移性去势抵抗性前列腺癌（mCRPC）患者进行[(161)Tb]Tb-PSMA-617放射性激光治疗的试点研究结果显示，在接受常规PSMA放射性激光治疗后，转移性去势抵抗性前列腺癌（mCRPC）患者接受[(161)Tb]Tb-PSMA-617放射性激光治疗后，患者在接受[(161)Tb]Tb-PSMA-617放射性激光

期刊:Theranostics
影响因子:13.3
doi:10.7150/thno.115831
Rosar, Florian; Burgard, Caroline; Petrescu, Christine; Blickle, Arne; Bartholomä, Mark; Maus, Stephan; Bastian, Moritz B; Speicher, Tilman; Schaefer-Schuler, Andrea; Ezziddin, Samer
肿瘤
前列腺癌
肿瘤免疫
CRP
发表日期：2025
文献求助 收藏

(131)I SPECT/CT provides prognostic information in patients with differentiated thyroid cancer

(131)I SPECT/CT 可为分化型甲状腺癌患者提供预后信息

期刊:European Journal of Nuclear Medicine and Molecular Imaging
影响因子:7.6
doi:10.1007/s00259-025-07187-1
Heinrich, Marieke; Blickle, Elias; Hartrampf, Philipp E; Hasenauer, Natalie; Kosmala, Aleksander; Kerscher, Alexander; Schlegel, Nicolas; Verburg, Frederik A; Buck, Andreas K; Michalski, Kerstin
甲状腺癌
肿瘤
肿瘤免疫
免疫/内分泌
发表日期：2025
文献求助 收藏

Expanding the scope of PSMA-RLT: evaluating treatment in challenging mCRPC patients with poor performance status (ECOG 3)

扩大 PSMA-RLT 的应用范围：评估对体能状态较差（ECOG 3）的难治性 mCRPC 患者的治疗效果

期刊:European Journal of Nuclear Medicine and Molecular Imaging
影响因子:7.6
doi:10.1007/s00259-025-07346-4
Bastian, Moritz B; Wörl, Benedikt; Blickle, Arne; Burgard, Caroline; Speicher, Tilman; Bartholomä, Mark; Schaefer-Schuler, Andrea; Maus, Stephan; Ezziddin, Samer; Rosar, Florian
CRP
发表日期：2025
文献求助 收藏

Safety of PSMA radioligand therapy in mCRPC patients with preexisting moderate to severe thrombocytopenia

PSMA放射性配体疗法在伴有中度至重度血小板减少症的mCRPC患者中的安全性

期刊:European Journal of Nuclear Medicine and Molecular Imaging
影响因子:7.6
doi:10.1007/s00259-024-07006-z
Bastian, Moritz B; Sieben, Maike; Blickle, Arne; Burgard, Caroline; Speicher, Tilman; Bartholomä, Mark; Schaefer-Schuler, Andrea; Maus, Stephan; Ezziddin, Samer; Rosar, Florian
血小板
CRP
发表日期：2025
文献求助 收藏

PSMA PET/CT in biochemical recurrence of prostate cancer with PSA levels ≤ 0.2 ng/mL: a German multicenter analysis of conventional PSMA tracers, including [(68)Ga]Ga-PSMA-11, [(68)Ga]Ga-PSMA I&T, and [(18)F]PSMA-1007

PSMA PET/CT 在 PSA 水平 ≤ 0.2 ng/mL 的前列腺癌生化复发中的应用：一项德国多中心分析，研究了包括 [(68)Ga]Ga-PSMA-11、[(68)Ga]Ga-PSMA I&T 和 [(18)F]PSMA-1007 在内的常规 PSMA 示踪剂。

期刊:European Journal of Nuclear Medicine and Molecular Imaging
影响因子:7.6
doi:10.1007/s00259-025-07292-1
Burgard, Caroline; Frei, Madita; Blickle, Arne; Hartrampf, Philipp E; Hoffmann, Manuela A; Schreckenberger, Mathias; Schmid, Hans-Peter; Unterrainer, Lena; Rogasch, Julian; Galler, Markus; Ezziddin, Samer; Rosar, Florian
肿瘤
前列腺癌
肿瘤免疫
PSA
发表日期：2025
文献求助 收藏

Pretreatment Fatigue in Breast Cancer Patients: Comparison With Healthy Controls and Associations With Biopsychosocial Variables

乳腺癌患者治疗前疲劳：与健康对照组的比较及与生物心理社会变量的关联

期刊:Cancer Medicine
影响因子:3.1
doi:10.1002/cam4.70404
Blickle, Patricia; Schmidt, Martina E; Steindorf, Karen
肿瘤
肿瘤免疫
乳腺癌
发表日期：2025
文献求助 收藏

Prediction of lesion-based response to PRRT using baseline somatostatin receptor PET

利用基线生长抑素受体PET预测病灶对肽受体放射性核素治疗（PRRT）的反应

期刊:Frontiers in Medicine
影响因子:3
doi:10.3389/fmed.2025.1523862
Aouf, Anas; Speicher, Tilman; Blickle, Arne; Bastian, Moritz B; Burgard, Caroline; Rosar, Florian; Ezziddin, Samer; Sabet, Amir
信号转导
发表日期：2025
文献求助 收藏

Tolerability of PSMA radioligand therapy in metastatic prostate cancer patients with baseline mild to moderate leukopenia

PSMA放射性配体疗法在基线轻度至中度白细胞减少的转移性前列腺癌患者中的耐受性

期刊:Ejnmmi Research
影响因子:3
doi:10.1186/s13550-025-01280-0
Bastian, Moritz B; Speicher, Tilman; Blickle, Arne; Burgard, Caroline; Bastian, Julius L D; Bartholomä, Mark; Schaefer-Schuler, Andrea; Maus, Stephan; Ezziddin, Samer; Rosar, Florian
细胞生物学
肿瘤
前列腺癌
肿瘤免疫
发表日期：2025
文献求助 收藏